Article Information
Published By
Online ISSN
History
- Received August 19, 2022
- Accepted January 18, 2023
- Published online March 23, 2023.
Article Versions
- You are currently viewing a previous version of this article (March 23, 2023 - 07:47).
- View the most recent version of this article
Copyright & Usage
Copyright ©The authors 2023 This version is distributed under the terms of the Creative Commons Attribution Non-Commercial Licence 4.0. For commercial reproduction rights and permissions contact permissions@ersnet.org
Author Information
- 1Patient Centered Science, BioPharmaceuticals Medical, AstraZeneca, Gaithersburg, MD, USA
- 2Late Stage Respiratory and Immunology, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA
- 3Patient Centered Science, BioPharmaceuticals Medical, AstraZeneca, Gothenburg, Sweden
- 4Patient Centered Solutions, IQVIA, Madrid, Spain
- 5Division of Molecular and Clinical Medicine, University of Dundee, Dundee, UK
- Corresponding author: Vivian Shih (vivian.shih{at}astrazeneca.com)
Funding
AstraZeneca
Article usage
Altmetrics
Vol 9 Issue 3
Table of Contents
The Bronchiectasis Exacerbation Diary: A Novel PRO for Non-Cystic Fibrosis Bronchiectasis
